Medicine / D-0876-2026
U.S. Food and Drug AdministrationD-0876-2026
Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05
Class II Distributed nationwide or U.S.-wide
Status: Ongoing
What was recalled
Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05
Recalling firm
Par Health USA, LLC
Reason for recall
Crystallization
Where it went
U.S. Nationwide
Shown as U.S. Food and Drug Administration published it (shortened where marked …). Recall Shelf does not change recall facts and is not affiliated with the agency.